Celldex Therapeutics (CLDX) Cash & Equivalents (2010 - 2026)
Celldex Therapeutics (CLDX) posted Cash & Equivalents of $47.45 million for Q2 2026, up 105.9% from $23.04 million a year earlier and up 32.8% from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Celldex Therapeutics' Cash & Equivalents came in at $28.87 million, up 1.8% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -8.0% (FY2020 to FY2025).
- In prior years, Celldex Therapeutics' Cash & Equivalents was $28.36 million in FY2024 (-18.6%), $34.81 million in FY2023 (+18.3%), $29.43 million in FY2022 (-24.8%) and $39.14 million in FY2021 (-10.7%).
- The Q2 2026 figure stands as the highest quarterly Cash & Equivalents since Q1 2024.
- On a year-over-year basis, Cash & Equivalents has increased in each of the last three quarters, with growth averaging 17.2% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q3 2021, with growth of 297.7%; the weakest was Q1 2025, with a decline of 85.1%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $35.73 million (Q1 2026), $28.87 million (Q4 2025) and $36.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Celldex Therapeutics | 2.54 Bn | 2.54 Bn | - | 47.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.45 Mn |
| Mar 31, 2026 | 35.73 Mn |
| Dec 31, 2025 | 28.87 Mn |
| Sep 30, 2025 | 36.04 Mn |
| Jun 30, 2025 | 23.04 Mn |
| Mar 31, 2025 | 17.14 Mn |
| Dec 31, 2024 | 28.36 Mn |
| Sep 30, 2024 | 36.40 Mn |
| Jun 30, 2024 | 42.74 Mn |
| Mar 31, 2024 | 115.08 Mn |
| Dec 31, 2023 | 34.81 Mn |
| Sep 30, 2023 | 21.13 Mn |
| Jun 30, 2023 | 28.22 Mn |
| Mar 31, 2023 | 54.12 Mn |
| Dec 31, 2022 | 29.43 Mn |
| Sep 30, 2022 | 18.58 Mn |
| Jun 30, 2022 | 28.40 Mn |
| Mar 31, 2022 | 25.29 Mn |
| Dec 31, 2021 | 39.14 Mn |
| Sep 30, 2021 | 72.18 Mn |
API Access
Celldex Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();